BIRKATIL Trademark

Trademark Overview

On Wednesday, August 25, 2010, a trademark application was filed for BIRKATIL with the United States Patent and Trademark Office. The USPTO has given the BIRKATIL trademark a serial number of 85115667. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 6, 2013. This trademark is owned by Successpharm GmbH. The BIRKATIL trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of Alzheimer's disease, Parkinson's disease, chronic fatigue syndrome, depression, immunodeficiency syndrome, cancer, obesity, coronary heart disease, diabetes, menopause and ophthalmological diseases
birkatil

General Information

Serial Number85115667
Word MarkBIRKATIL
Filing DateWednesday, August 25, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 6, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 8, 2011

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of Alzheimer's disease, Parkinson's disease, chronic fatigue syndrome, depression, immunodeficiency syndrome, cancer, obesity, coronary heart disease, diabetes, menopause and ophthalmological diseases
Translation of Words in MarkThe wording "BIRKATIL" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 30, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSuccesspharm GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressVienna A-1190
AT
Party NameSuccesspharm GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressVienna A-1190
AT

Trademark Events

Event DateEvent Description
Monday, May 6, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 6, 2013ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 10, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 9, 2012EXTENSION 3 GRANTED
Friday, October 5, 2012EXTENSION 3 FILED
Friday, October 5, 2012TEAS EXTENSION RECEIVED
Friday, April 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 19, 2012EXTENSION 2 GRANTED
Friday, March 23, 2012EXTENSION 2 FILED
Thursday, April 19, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 23, 2012TEAS EXTENSION RECEIVED
Friday, October 7, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 5, 2011EXTENSION 1 GRANTED
Wednesday, October 5, 2011EXTENSION 1 FILED
Wednesday, October 5, 2011TEAS EXTENSION RECEIVED
Tuesday, April 5, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 8, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 8, 2011PUBLISHED FOR OPPOSITION
Monday, January 3, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, January 3, 2011ASSIGNED TO LIE
Wednesday, December 8, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 8, 2010EXAMINER'S AMENDMENT ENTERED
Wednesday, December 8, 2010EXAMINER'S AMENDMENT ENTERED
Wednesday, December 8, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 8, 2010EXAMINERS AMENDMENT E-MAILED
Wednesday, December 8, 2010EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 8, 2010ASSIGNED TO EXAMINER
Monday, August 30, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 28, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

birkatil disease syndrome coronary obesity heart diabetes ophthalmological menopause cancer diseases